XTL Biopharmaceuticals Ltd. American Depositary Shares

Go to XTL Biopharmaceuticals Ltd. American Depositary Shares Website

$1.45

-0.26 (-15.20%)
Live
Previous Close

$1.45

Day Range

$1.4 - $1.59

Previous Day Range

$1.39 - $1.81

Market Cap

$15.1 million USD

Day Vol.

14699

Previous Day Vol.

19648

Currency

USD

Primary Exchange

Nasdaq

XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a m...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

XTL Biopharmaceuticals, an Israeli pharmaceutical company, announced the results of its Annual and Extraordinary General Meeting, including the re-election of board members and the appointment of independent auditors. The company also confirmed the acquisition of The Social Proxy Ltd., which will add two new directors to its board.

Related tickers: XTLB.

Read Full Article

expands its IP portfolio to AI Web Data

Related tickers: XTLB.

Read Full Article
Trending Tickers

Please sign in to view